Searchable abstracts of presentations at key conferences in endocrinology

ea0011p94 | Clinical case reports | ECE2006

Systemic amyloidosis presenting with thyrotoxicosis: a case report

Fegan G , Rasbridge S , Taylor M

Although amyloid deposition can cause a goitre thyrotoxicosis secondary to amyloidosis is rare. We report a case of fatal systemic amyloidosis presenting as thyrotoxicosis.A 62-year-old previously healthy male presented with heat intolerance, weight loss and tremor. On examination he had moderate sized firm goitre and mild dysthyroid eye disease. Biochemistry confirmed thyrotoxicosis; serum free T4 47 pmol/l (normal 10–25) freeT3 14.4 pmol/l (normal...

ea0005p116 | Endocrine Tumours and Neoplasia | BES2003

Dysregulated extra-renal synthesis of 1,25-dihydroxyvitamin D3: A novel cause of hypercalcemia associated with ovarian dysgerminomas

Evans K , Zehnder D , Kilby M , Taylor H , Hewison M

Hypercalcaemia is a prevalent complication in malignancies as a consequence of tumor secretion of parathyroid hormone related peptide (PTHrP). This complication is also associated with ovarian dysgerminomas but is much less common than for other tumours. To investigate this further we have studied 10 cases of dysgerminoma, assessing biochemical parameters and analysing mRNA and protein expression in tissue biopsies. Pathological reports show raised serum calcium and 1,25(OH)<s...

ea0044p79 | Clinical biochemistry | SFEBES2016

Immunoassay cortisol day curve dangerously overestimates cortisol reserve in a metyrapone treated patient

Leong Christine H M , Taylor David R , Gilbert Jackie , Whitelaw Benjamin C

Background: Metyrapone is commonly used in medical management of Cushing’s syndrome. It inhibits 11-β hydroxylase, which catalyses the conversion of 11-deoxycortisol to cortisol. The adequacy of metyrapone blockade can be assessed either clinically or biochemically using a target mean serum cortisol 150–300 nmol/l. Cortisol is normally measured by immunoassay.Case report: A 21-year-old female presented with clinical and biochemical feature...

ea0044p80 | Clinical biochemistry | SFEBES2016

Cortisol measurement using immunoassay versus liquid chromatography-tandem mass spectrometry: metyrapone dose-related discrepancies in cortisol values

Leong Christine H M , Taylor David R , Whitelaw Benjamin C , Aylwin Simon

Background: Metyrapone inhibits 11-β hydroxylase and causes a subsequent rise in the cortisol precursor, 11-deoxycortisol. Cortisol measurements by immunoassays are susceptible to interference and reagent antibody cross-reactivity with cortisol precursors when used in patients receiving metyrapone treatment. Clinicians rely on clinical and biochemical features of cortisol excess for dose titration of this medical blockade. The extent of this interference remains unclear. ...

ea0015p328 | Steroids | SFEBES2008

Non-alcoholic fatty liver disease is associated with transcriptional dysregulation of 11β-hydroxysteroid dehydrogenase type 1 leading to excess intrahepatic glucocorticoid exposure

Coyle F M , Taylor N F , Feakins R , Monson J P , Drake W M , Foster G R

Background: Glucocorticoids play a key role in determining body fat distribution. Excess circulating glucocorticoids lead to intrahepatic fat accumulation. Obesity is associated with enhanced glucocorticoid production but this is offset by enhanced degradation such that circulating steroid concentrations are normal. However, tissue-specific pathways may lead to different degrees of cortisol exposure in different organs. Local steroid exposure in the liver is determined by the ...

ea0010p28 | Diabetes, metabolism and cardiovascular | SFE2005

Ghrelin enhances gastric emptying in diabetic gastroparesis

Murray C , Martin N , Patterson M , Taylor S , Ghatei M , Kamm M , Johnston C , Bloom S , Emmanuel A

Background: Diabetic gastroparesis is a disabling condition with no consistently effective treatment. Ghrelin infusion, in animal studies, increases gastric emptying and reverses post-operative ileus. We present the results of the first double-blind placebo-controlled cross-over study of ghrelin in gastric emptying in patients with diabetic gastroparesis....

ea0010dp7 | Diabetes, metabolism and cardiovascular | SFE2005

Ghrelin enhances gastric emptying in diabetic gastroparesis

Murray C , Martin N , Patterson M , Taylor S , Ghatei M , Kamm M , Johnston C , Bloom S , Emmanuel A

BackgroundDiabetic gastroparesis is a disabling condition with no consistently effective treatment. Ghrelin infusion, in animal studies, increases gastric emptying and reverses post-operative ileus. We present the results of the first double-blind placebo-controlled cross-over study of ghrelin in gastric emptying in patients with diabetic gastroparesis.MethodsTen insulin requiring diabetic patients (5 men, 6 ...

ea0037gp.05.06 | Developmental and paediatric endocrinology | ECE2015

Comparison of seven LC–MS/MS methods for the simultaneous measurement of testosterone, androstenedione, and DHEA in serum

Buttler Rahel M , Martens Frans , Fanelli Flaminia , Keevil Brian G , Pham Hai T , Kushnir Mark M , Taylor Angela E , Soeborg Tue , Blankenstein Marinus A , Heijboer Annemieke C

Recently, liquid chromatography–tandem mass spectrometry (LC–MS/MS) was stated to be the method of choice to measure sex steroids.1 Information on the mutual agreement of LC–MS/MS methods, however, is scarce. Therefore, we compared seven published LC–MS/MS methods for the simultaneous measurement of testosterone, androstenedione, and DHEA. Fifty-five random serum samples obtained from volunteers were analysed in duplicate by seven published LC&#1...